These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 28530056

  • 1. [CUTANEOUS LEISHMANIASIS IN ISRAEL 2016 - AN UPDATE].
    Solomon M, Schwartz E.
    Harefuah; 2016 Oct; 155(10):626-631. PubMed ID: 28530056
    [Abstract] [Full Text] [Related]

  • 2. Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica.
    Solomon M, Pavlotsky F, Leshem E, Ephros M, Trau H, Schwartz E.
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):973-7. PubMed ID: 21129042
    [Abstract] [Full Text] [Related]

  • 3. Changing patterns of cutaneous leishmaniasis in Israel and neighbouring territories.
    Klaus S, Axelrod O, Jonas F, Frankenburg S.
    Trans R Soc Trop Med Hyg; 1994 Aug; 88(6):649-50. PubMed ID: 7886757
    [Abstract] [Full Text] [Related]

  • 4. Leishmania tropica in northern Israel: a clinical overview of an emerging focus.
    Shani-Adir A, Kamil S, Rozenman D, Schwartz E, Ramon M, Zalman L, Nasereddin A, Jaffe CL, Ephros M.
    J Am Acad Dermatol; 2005 Nov; 53(5):810-5. PubMed ID: 16243129
    [Abstract] [Full Text] [Related]

  • 5. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis.
    Solomon M, Baum S, Barzilai A, Scope A, Trau H, Schwartz E.
    J Am Acad Dermatol; 2007 Apr; 56(4):612-6. PubMed ID: 17276541
    [Abstract] [Full Text] [Related]

  • 6. Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers.
    Solomon M, Pavlotzky F, Barzilai A, Schwartz E.
    J Am Acad Dermatol; 2013 Feb; 68(2):284-9. PubMed ID: 22858005
    [Abstract] [Full Text] [Related]

  • 7. Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 1.
    Zur E.
    Int J Pharm Compd; 2019 Feb; 23(3):200-207. PubMed ID: 31085788
    [Abstract] [Full Text] [Related]

  • 8. Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2.
    Zur E.
    Int J Pharm Compd; 2019 Feb; 23(4):288-293. PubMed ID: 31315079
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of Systemic Treatment for Leishmania tropica Cutaneous Leishmaniasis.
    Solomon M, Greenberger S, Milner M, Pavlotzky F, Barzilai A, Schwartz E, Hadayer N, Baum S.
    Acta Derm Venereol; 2022 May 24; 102():adv00721. PubMed ID: 35229163
    [Abstract] [Full Text] [Related]

  • 10. Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3.
    Zur E.
    Int J Pharm Compd; 2019 May 24; 23(5):366-375. PubMed ID: 31513534
    [Abstract] [Full Text] [Related]

  • 11. Cutaneous leishmaniasis caused by Leishmania infantum in Southern Israel.
    Ben-Shimol S, Sagi O, Horev A, Avni YS, Ziv M, Riesenberg K.
    Acta Parasitol; 2016 Dec 01; 61(4):855-858. PubMed ID: 27787222
    [Abstract] [Full Text] [Related]

  • 12. Treatment outcome of imported cutaneous leishmaniasis among travelers and migrants infected with Leishmania major and Leishmania tropica: a retrospective study in European centers 2013 to 2019.
    Glans H, Dotevall L, Van der Auwera G, Bart A, Blum J, Buffet P, Guery R, Gangneux JP, van Henten S, Harms G, Varani S, Robert-Gangneux F, Rongisch R, Andersson B, Bradley M.
    Int J Infect Dis; 2022 Sep 01; 122():375-381. PubMed ID: 35728749
    [Abstract] [Full Text] [Related]

  • 13. Leishmania tropica in children: a retrospective study.
    Solomon M, Schwartz E, Pavlotsky F, Sakka N, Barzilai A, Greenberger S.
    J Am Acad Dermatol; 2014 Aug 01; 71(2):271-7. PubMed ID: 24775403
    [Abstract] [Full Text] [Related]

  • 14. Cutaneous leishmaniasis treatment.
    Minodier P, Parola P.
    Travel Med Infect Dis; 2007 May 01; 5(3):150-8. PubMed ID: 17448941
    [Abstract] [Full Text] [Related]

  • 15. [Cutaneous leishmaniasis treated with ambisome (liposomal amphotericin B)].
    Ben-Shimol S, Sagi O, Schwartz E, Greenberg D.
    Harefuah; 2012 Aug 01; 151(8):458-60, 498. PubMed ID: 23350289
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cutaneous Leishmaniasis Treated with Miltefosine: A Case Series of 10 Paediatric Patients.
    Ollech A, Solomon M, Horev A, Reiss-Huss S, Ben-Amitai D, Zvulunov A, Friedland R, Atar-Snir V, Pessach-Molcho V, Barzilai A, Greenberger S.
    Acta Derm Venereol; 2020 Nov 18; 100(18):adv00322. PubMed ID: 33205828
    [Abstract] [Full Text] [Related]

  • 19. Cutaneous Leishmaniasis Treated with Miltefosine: A Case Series of 10 Paediatric Patients.
    Ollech A, Solomon M, Horev A, Reiss-Huss S, Ben-Amitai D, Zvulunov A, Friedland R, Atar-Snir V, Molho-Pessach V, Barzilai A, Greenberger S.
    Acta Derm Venereol; 2020 Oct 19; 100(18):adv00322. PubMed ID: 33074340
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of miltefosine in cutaneous leishmaniasis caused by Leishmania tropica in Pakistan after antimonial treatment failure or contraindications to first line therapy-A retrospective analysis.
    Kämink S, Masih B, Ali N, Ullah A, Khan SJ, Ashraf S, Pylypenko T, Grobusch MP, Fernhout J, den Boer M, Ritmeijer K.
    PLoS Negl Trop Dis; 2021 Jan 19; 15(1):e0008988. PubMed ID: 33507944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.